World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
18096
World Ranking
15824
National Ranking
7963

Overview

Susan M. Blaney is affiliated with Baylor College of Medicine in the United States. Their research contributions primarily span the fields of medicine and biochemistry, genetics, and molecular biology. Specific subfields include molecular biology, oncology, genetics, neurology, and pulmonary and respiratory medicine.

The main topics of Blaney's research involve neuroblastoma research and treatments, glioma diagnosis and treatment, cancer therapeutics and mechanisms, histone deacetylase inhibitors research, lung cancer treatments and mutations, cancer, hypoxia, and metabolism, as well as genomics and chromatin dynamics.

Their recent publications demonstrate an active role in cancer research, particularly pediatric cancers and brain tumors. Notable papers include:

  • Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912), 2021, Clinical Cancer Research
  • ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma, 2021, Cancer Discovery
  • A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study, 2020, Neuro-Oncology
  • A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma, 2020, Pediatric Blood & Cancer
  • Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report, 2021, Neuro-Oncology

Blaney frequently collaborates with several researchers, including Brenda J. Weigel, Charles G. Minard, Frank M. Balis, Elizabeth Fox, and Peter C. Adamson. These collaborations reflect a multidisciplinary approach to cancer and brain tumor research.

The venues where Blaney has published recurrently include Neuro-Oncology, Clinical Cancer Research, Cancer Discovery, Pediatric Blood & Cancer, and the Journal of Clinical Oncology. These venues align with their focus on oncology and brain tumor research.

Best Publications

  • Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

    Yael P Mossé;Megan S Lim;Stephan D Voss;Keith Wilner

  • Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy

    Tanya M. Tekautz;Christine E. Fuller;Susan Blaney;Maryam Fouladi

  • Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma

    Ching-Hon Pui;Hazem H. Mahmoud;Joseph M. Wiley;Gerald M. Woods

  • Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

    Yael P. Mossé;Stephan D. Voss;Megan S. Lim;Delphine Rolland

  • Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group

    Stacey L. Berg;Susan M. Blaney;Meenakshi Devidas;Tom A. Lampkin

  • Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

    Roger J. Packer;Jaclyn A. Biegel;Susan Blaney;Jonathan Finlay

  • Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

    Julia L. Glade Bender;Peter C. Adamson;Joel M. Reid;Lu Xu

  • Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC

    Xiao Nan Li;Qin Shu;Jack Men Feng Su;Laszlo Perlaky

  • Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study.

    Martin A. Champagne;Renaud Capdeville;Mark Krailo;Wenchun Qu

  • Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

    Elizabeth A. Raetz;Mitchell S. Cairo;Michael J. Borowitz;Susan M. Blaney

  • A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.

    Mason Bond;Mark L. Bernstein;Alberto Pappo;Kirk R. Schultz

  • Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines.

    Ronald J. Bernardi;Amanda R. Lowery;Patrick A. Thompson;Susan M. Blaney

  • Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial.

    Sima Jeha;H. Kantarjian;D. Irwin;V. Shen

  • Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

    Suman Malempati;Brenda Weigel;Ashish M. Ingle;Charlotte H. Ahern

  • Expression Analysis of Juvenile Pilocytic Astrocytomas by Oligonucleotide Microarray Reveals Two Potential Subgroups

    Kwong Kwok Wong;Yi Mieng Chang;Yvonne T M Tsang;Laszlo Perlaky

  • Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report

    Maryam Fouladi;Julie R. Park;Clinton F. Stewart;Richard J. Gilbertson

  • Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas

    Brigitte C. Widemann;Wanda L. Salzer;Robert J. Arceci;Susan M. Blaney

  • Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.

    Ian F. Pollack;Regina I. Jakacki;Susan M. Blaney;Michael L. Hancock

  • Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

    Joanne P. Lagmay;Mark D. Krailo;Ha Dang;Ae Rang Kim

  • Bortezomib interactions with chemotherapy agents in acute leukemia in vitro

    Terzah M. Horton;Anurhadha Gannavarapu;Susan M. Blaney;David Z. D’Argenio

Frequent Co-Authors

Peter C. Adamson
Peter C. Adamson Children's Hospital of Philadelphia
Mark Krailo
Mark Krailo University of Southern California
Frank M. Balis
Frank M. Balis Children's Hospital of Philadelphia
Larry E. Kun
Larry E. Kun St. Jude Children's Research Hospital
James M. Boyett
James M. Boyett St. Jude Children's Research Hospital
Roger J. Packer
Roger J. Packer Children’s National Health System
Clinton F. Stewart
Clinton F. Stewart St. Jude Children's Research Hospital
Ian F. Pollack
Ian F. Pollack University of Pittsburgh
Richard J. Gilbertson
Richard J. Gilbertson University of Cambridge
David G. Poplack
David G. Poplack Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degree programs in healthcare opens new doors for students and working professionals alike. One common concern is how much is online nursing school; tuition costs vary but many programs offer affordable paths compared to traditional on-campus routes.

For registered nurses aiming to advance, cheapest online rn to bsn programs allow for greater flexibility and career growth. These programs help RNs earn a Bachelor of Science in Nursing entirely online, often in an accelerated format and at a lower cost.

Those seeking leadership, teaching, or research roles may consider a phd in nursing online programs. Such programs offer rigorous academic training and open doors to advanced healthcare careers without interrupting current work schedules.

Additionally, direct entry msn programs for non nurses online are an ideal option for individuals with non-nursing bachelor’s degrees who want to quickly transition into advanced nursing practice.

Exploring these online pathways ensures more accessible, flexible opportunities to build a rewarding career in medicine and healthcare.

Best Scientists Citing Susan M. Blaney

Trending Scientists

Recently Published Articles